Cognis..... :(

Discussion in 'Boston Scientific' started by Anonymous, Mar 26, 2009 at 12:21 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Re: Anyone Knows about Cognis Conference call on this Sunday Morning?

    It's a Rif call. You're out my friend.
     

  2. Anonymous

    Anonymous Guest

    Re: Anyone Knows about Cognis Conference call on this Sunday Morning?

    I left BSX before Cognis and Telegin were prematurally released!
     
  3. Anonymous

    Anonymous Guest

    Are these cans still implanted?
     
  4. Anonymous

    Anonymous Guest

    Yes but in low volume.
     
  5. Anonymous

    Anonymous Guest

    Why are these devices are in the news again?
     
  6. Anonymous

    Anonymous Guest

    I think some of the cans were sub-standard and they were sold and implanted. People who matter has now woken up and demanding answers.

    I am sure lots of dirt will show now
     
  7. Anonymous

    Anonymous Guest

    No dirt or anything came out. These cans were the best ICDs ever designed and manufactured by BSC.
     
  8. Anonymous

    Anonymous Guest

    1. Headers fall off.

    2. Burp headers.

    3. Bad transformer.

    4. Early depletion.

    But yet the best cans thank you ever built. True statement.
     
  9. Anonymous

    Anonymous Guest

    The experience in managing Cognis/Teligen problems provided BSX design, manufacture, assembly, testing and procurement areas, a rare chance to update their knowledge in design of headers and titanium cans; how to purchase and qualify set-screws and O-rings; the care in selection of header material and adhesives so that everything stay secure with cans even after implant.

    The New Year resolution for BSX: Never ever hurry the market release of products.
     
  10. Anonymous

    Anonymous Guest

    +1
     
  11. Anonymous

    Anonymous Guest

    Isn't that one of the manufacturing goals.... For "everything to stay secure with cans even after implant"?
     
  12. Anonymous

    Anonymous Guest

    Of course!

    But, hey, goals have to be prioritized, right? Right?

    Alls we're saying is, based on our "rare chance" to experience C/T issues, we've redrawn our list.

    Having the cans not fall apart is alot closer to the top, now, like top 5...top 3 if we're talking bulk purchases for GPO's....
     
  13. Anonymous

    Anonymous Guest

    In is unfortunate that BSX has to take all the blame. The major issues are mostly due to Bio leads failing to stay in the header to provide good conductivity. Bio has failed to supply reliable leads.

    The best bet for the year 2015 would be to design and manufacture leads inhouse so that everything work together.
     
  14. Anonymous

    Anonymous Guest

    All Bio lead designs are from Germany and their products are reliable. I thought that BSX former CTO was a German Engineer.
     
  15. Anonymous

    Anonymous Guest

    Bsx doesnt use Bio tachy leads you moron.

    They only buy brady leads from Bio...
     
  16. Anonymous

    Anonymous Guest

    Do you mean in C/T cans only tachy leads got loose in the lead port resulting failed therapy; and brady leads stayed secure?

    That means full credits to Bio.

    You guys cannot even source and validate simple hardware like set screws, glue and O-rings, how can you boast about tachy leads used in C/T cans were good and effective in providing shocks? You were wrongly blaming software is it not?
     
  17. Anonymous

    Anonymous Guest

    Are u a tard? Just checking.
     
  18. Anonymous

    Anonymous Guest

    You cannot! As I jumped ship when you guys started salvaging a large number of failed headers on C/T cans with a view to resell them without any revalidation. It may be that FDA was ignorant of these secret operations.
     
  19. Anonymous

    Anonymous Guest

    It is not uncommon this type of issues at Boston Scientific. They have done many illegal things and think that with their arsenal of attorneys they can get away with it as long as they have you in courts.
    Soon there will be many documentations released publicly that will bring a new light on subject to Boston scientific and its approach to doing business , with many as much as 23,000 cases of law cases in courts such as transvaginal mesh and other criminal activities in other division it will be hard to believe that the stock will continue to climb as they predicted in the last wall street market watch to be $18.0 per share not unless it is artificially manipulated as many other violation they are accustomed to.

    Soon the news will be out for the public and investors to make the correction that is required or initiate a class action case that is beyond their comprehension.
    there are many evidences that are coming up and others pending that will be crucial and impossible for Bosotn scientific so called leadership to ignore and continue to cover up.
     
  20. Anonymous

    Anonymous Guest

    Obviously English is not this guys first language.